(Q35818052)

10 August 2017

Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime (English)

1 reference

multicenter clinical trial

10 August 2017

0 references

1 reference

1 reference

2

Jones RN

1 reference

10 August 2017

6

Knapp CC

1 reference

10 August 2017

1

Washington JA

1 reference

10 August 2017

3

Gerlach EH

1 reference

10 August 2017

Murray PR

4

1 reference

PMCID

188045

10 August 2017

Allen SD

series ordinal

5

1 reference

PMCID

188045

10 August 2017

language of work or name

English

0 references

publication date

1 August 1993

1 reference

Antimicrobial Agents and Chemotherapy

10 August 2017

1 reference

10 August 2017

37

1 reference

10 August 2017

8

1 reference

10 August 2017

1696-1700

1 reference

In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188045

In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188045

In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188045

Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188045

Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidime

11 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8215286

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Activity of cefepime, ceftazidime, and ceftizoxime against mutants of Enterobacteriaceae and Pseudomonas aeruginosa derepressed for class I beta-lactamase

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8215286

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.37.8.1696

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

PMCID

188045